Keiske Okada
Papers
1
Total Citations
2
H-Index
1
About
Dr. Keiske Okada is a dedicated clinician-researcher whose work centers on the long-term oncological outcomes of pediatric cancer survivors, with a particular focus on secondary malignancies and renal cell carcinoma (RCC). In his most-cited study, a 2023 case report and literature review, Dr. Okada documented a rare instance of TFE3 gene translocation-associated RCC in the contralateral kidney of a child who had previously undergone chemoradiotherapy for nephroblastoma. This contribution underscores a critical clinical message: while secondary RCC following childhood cancer treatment is uncommon, it warrants vigilant surveillance. By highlighting the genetic and therapeutic complexities of such cases, his work informs both pediatric oncology and urological practice. Though his citation count is still growing, Dr. Okada’s research has already provided a valuable framework for recognizing and managing late effects of cancer therapy. His findings serve as a cautionary guide for clinicians, emphasizing the need for long-term monitoring of childhood cancer survivors to detect rare but serious secondary neoplasms.
Research Focus
Key Achievements
Top Papers
- 1